Seqens Seqens

X

Find Radio Compass News for MolPort-001-783-406

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - 6MG/ML
  • TABLET;ORAL - 2MG

https://www.thepharmaletter.com/in-brief/brief-two-japanese-drug-approvals-for-otsuka-busulfex-and-rexulti?__cf_chl_jschl_tk__=pmd_.W9CAGWFIxVQa8SGiCBZJJxulaUx0plWDleiTL7DZWU-1629974977-0-gqNtZGzNAmWjcnBszQil

THEPHARMALETTER
25 Aug 2021

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-16-2020-1608097779.pdf

FDA
16 Dec 2020

https://www.businesswire.com/news/home/20200504005106/en/AVROBIO-Collaborate-Saladax-Biomedical-New-High-Speed-Diagnostic

BUSINESSWIRE
03 May 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210931

FDA
23 Apr 2019

https://www.prnewswire.com/news-releases/pii-to-manufacture-fda-approved-busulfan-injection-drug-product-300813167.html

PR NEWSWIRE
18 Mar 2019

https://www.contractpharma.com/contents/view_breaking-news/2019-03-15/pii-to-manufacture-busulfan-injection-drug-product/

CONTACT PHARMA
15 Mar 2019

https://www.globenewswire.com/news-release/2019/03/13/1752374/0/en/SunGen-Pharma-and-Athenex-Pharmaceutical-Division-Announce-Busulfan-Injection-Product-Launch.html

GLOBENEWSWIRE
14 Mar 2019

https://www.businesswire.com/news/home/20190116005876/en/Nexus-Pharmaceuticals-announces-FDA-approval-Busulfan-Injection

BUSINESSWIRE
17 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207794

FDA
14 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205672

FDA
31 Jul 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205184

FDA
20 Jul 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210079

FDA
30 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206218

FDA
20 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205139

FDA
12 Dec 2017

https://www.prnewswire.com/news-releases/mylan-and-aspen-announce-launch-of-generic-busulfex-injection-300565812.html

PR NEWSWIRE
04 Dec 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208536

FDA
22 Nov 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207050

FDA
24 Mar 2017

https://www.bloomberg.com/news/articles/2017-01-30/old-cancer-drug-gets-1-000-plus-price-hike-in-frugal-u-k

N Kresge BLOOMBERG
31 Jan 2017

https://www.pharmacompass.com/pdf/news/pharmaforces-generic-busulfan-approved-in-us-for-chronic-myeloid-leukemia-1451557266.pdf

FDA
28 Dec 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY